The type III secretion effector NleE inhibits NF-kappaB activation

Area of Science:

• Microbiology
• Immunology
• Molecular Biology

Background:

• Host-pathogen interactions involve innate immune recognition and pathogen countermeasures.
• Bacterial detection activates the transcription factor NF-kappaB, leading to inflammation and pathogen clearance.
• Some pathogens, like enteropathogenic Escherichia coli (EPEC), have evolved mechanisms to evade immune responses by inhibiting NF-kappaB activation.

Purpose of the Study:

• To investigate the molecular mechanisms by which EPEC inhibits host NF-kappaB activation.
• To identify the specific bacterial effectors involved in manipulating NF-kappaB signaling pathways.

Main Methods:

• Investigated the role of injected effector proteins in EPEC's inhibition of NF-kappaB.
• Analyzed the impact of EPEC effectors on IKKbeta activation and IkappaB degradation.
• Characterized the functions of novel EPEC effectors NleB and NleE.

Main Results:

• EPEC inhibits NF-kappaB activation through the injection of effector protein NleE into host cells.
• NleE directly prevents the activation of IKKbeta, thereby inhibiting the degradation of IkappaB.
• NleE's inhibitory activity on NF-kappaB is enhanced by, but not dependent on, another effector, NleB.
• NleB and NleE are novel proteins with no known similarity to other proteins.

Conclusions:

• EPEC employs a novel two-effector system (NleB and NleE) to subvert host NF-kappaB signaling.
• NleE is a key virulence factor that directly targets the IKKbeta-IkappaB-NF-kappaB axis.
• These findings reveal new strategies used by pathogens to manipulate host innate immunity.